QU╔BEC CITY, Feb. 23 /PRNewswire-FirstCall/ - Ăterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company"), a late-stage drug development company specializedin oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital
A live audio webcast of the panel discussion will be available in the Investors section of the Company's website at www.aezsinc.com. A replay of the webcast will also be available on its website for a period of 30 days.
About Ăterna Zentaris Inc.
Ăterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Subscribe to our Free Newsletters!